EyePoint, Inc. cotiza a 3.07 USD y tiene una capitalización bursátil de $265M. En los últimos 12 meses ha facturado $3M con un margen de flujo de caja libre del -775.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sust…
| Métrica | EYPT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -776.0% | -38.6% | -737.4% |
| Net Margin | -739.4% | -33.6% | -705.9% |
| FCF Margin | -775.8% | -13.9% | -762.0% |
| ROE | -75.8% | -40.4% | -35.4% |
| ROA | -63.7% | -32.0% | -31.7% |
| Current Ratio | 8.88 | 2.84 | +6.04 |
| Debt / Equity | — | 0.28 | — |